Author: healthadmin
Emerging pharmaceutical companies face increasing pressure to scale quickly while managing lean teams, limited resources, and rising expectations for agent AI. On this episode of The Top Line, Fierce Biotech host Kelly Hogan is joined by JR Raelin, executive director of analytics and insights at SynOx Therapeutics, and Krishna GS, business technology solutions manager at ZS, to discuss why execution, not insight, is often the biggest challenge.Raelin and Krishna outline common technology roadmap mistakes for young and emerging organizations, including pursuing new technologies and AI without a strong data foundation, allowing the proliferation of siled point solutions, and under-investing in…
Bayer’s proposed $7.25 billion class action settlement is a “sweet deal” that violates the U.S. Constitution and “wildly violates fundamental due process rights,” one person said. Submission to court It’s an attempt to get the national plan back on track. The challenge, filed Thursday in St. Louis City Circuit Court in Missouri, Settlement proposal proposed by Bayer A group of plaintiffs’ lawyers announced in February. Following this application, “Notice of deletion” On Friday, it seeks to move the case to federal court, where its future could be in jeopardy. Bayer hopes the settlement agreement will resolve tens of thousands of…
Since their discovery in the 1950s, metallocenes have played an important role in organometallic chemistry. These compounds have a metal atom placed between two carbon rings, forming a unique “sandwich” structure. Scientists have been studying their use in catalysts, advanced materials, energy technologies, sensors, and drug delivery systems for decades. Still, researchers have struggled to fully understand how these molecules form because many of the key intermediate steps are highly unstable and disappear almost instantly. Scientists at Okinawa Institute of Science and Technology University (OIST) have now successfully captured and fully characterized a rare intermediate structure involved in metallocene formation.…
Recent research published in Proceedings of the National Academy of Sciences suggests that political emotions are not just abstract thoughts, but distinctly felt physical experiences that shape engagement in democracy. This study provides evidence that people physically experience politically-driven emotions differently than they experience everyday emotions. These physical sensations reliably predict whether someone will actually participate in political actions such as voting or protesting. Scientists recognize that emotions drive political engagement and public division. However, how people physically experience these emotions remains largely unknown in political science. Political sentiment is typically measured by asking people to rate their feelings on…
Get the health information and medications you need every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning and happy Friday. I hope you have a great long weekend planned. But first, scroll down and read about the Senate hearings on the NIH, the Supreme Court’s death penalty decision, and two related items about the confusion surrounding sexually transmitted diseases. Mr Bhattacharya grilled in Senate hearing When National Institutes of Health Director Jay Bhattacharyya appeared before the Senate Appropriations Committee yesterday, the focus was supposed to be on the institute’s proposed budget for next year. But first,…
Merck & Co. and Cologne Biotech’s sac-TMT has been in the news this week with details or initial reports of three positive Phase 3 trials. Experts say local know-how, proper due diligence and AI will help in closing licensing deals in China. For the first time, a federal jury has found a drug company liable in a late payment lawsuit. moreover. 1. ASCO: Merck and Cologne’s sac-TMT ADC combo outperforms Keytruda by 65% in first-line lung cancer progression Merck and Cologne sac-TMT scores in endometrial cancer trials The combination of Merck & Cologne Biotech’s TROP2 antibody-drug conjugate sac-TMT with Keytruda…
Explore key 2025 clinical trials in gene editing, precision oncology, and CAR-T therapies, with insights for clinical researchers.
Scientists have applied chemical techniques used in traditional glass manufacturing to improve a futuristic material known as metal-organic framework (MOF) glass. These materials are made from metal atoms bonded with organic molecules and are prized for their ability to trap gases such as carbon dioxide and hydrogen, and even water. An international research team, including scientists from Dortmund University of Technology and the University of Birmingham, reported the following findings: natural chemistry Their research shows that MOF glasses can be tailored and designed using methods similar to those used for traditional glass for many years. Researchers have found that introducing…
New research shows that people with highly manipulative personalities have lower expectations for emotional intimacy in romantic relationships, with the strongest negative association being with older women. But our findings suggest that existing views about love and attachment habits shape connections more than negative personality traits alone. The study was published in Personality and Individual Differences. Cultivating deep intimacy is widely considered to be the cornerstone of psychological well-being. A supportive, trusting romantic relationship provides a psychological buffer against life’s stressors and improves overall mental health. When people struggle to form these bonds, they often experience feelings of isolation and…
Almost one in four adults over the age of 40 has painful osteoarthritis. This osteoarthritis can make daily activities difficult and is one of the leading causes of disability in adults. This disease causes the cartilage that cushions joints to gradually wear away. Once that damage occurs, doctors currently cannot reverse it. Treatment usually focuses on pain relief, with joint replacement surgery being an option when symptoms become severe. A clinical trial by researchers at the University of Utah, New York University, and Stanford University points to another possibility: changing the way people walk. Personalized foot angle changes In a…